{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:58:09Z","timestamp":1790510289371,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cbi.2017.06.020","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T04:45:16Z","timestamp":1498020316000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers"],"prefix":"10.1016","volume":"276","author":[{"given":"Maura","family":"Gasparetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.cbi.2017.06.020_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(00)00211-8","article-title":"Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism","volume":"129","author":"Vasiliou","year":"2000","journal-title":"Chem. Biol. Interact."},{"issue":"10","key":"10.1016\/j.cbi.2017.06.020_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.exphem.2012.05.014","article-title":"Varying levels of aldehyde dehydrogenase activity in adult murine marrow hematopoietic stem cells are associated with engraftment and cell cycle status","volume":"40","author":"Gasparetto","year":"2012","journal-title":"Exp. Hematol."},{"issue":"1\u20133","key":"10.1016\/j.cbi.2017.06.020_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","article-title":"Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells","volume":"202","author":"Vasiliou","year":"2013","journal-title":"Chem. Biol. Interact."},{"issue":"16","key":"10.1016\/j.cbi.2017.06.020_bib4","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.1073\/pnas.96.16.9118","article-title":"Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity","volume":"96","author":"Storms","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1182\/blood-2004-09-3652","article-title":"Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34","volume":"106","author":"Storms","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cbi.2017.06.020_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.2772","article-title":"Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?","volume":"222","author":"Alison","year":"2010","journal-title":"J.\u00a0Pathol."},{"issue":"3","key":"10.1016\/j.cbi.2017.06.020_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","article-title":"Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer","volume":"385","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.cbi.2017.06.020_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cncr.27737","article-title":"Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women","volume":"119","author":"Schwartz","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.cbi.2017.06.020_bib9","doi-asserted-by":"crossref","first-page":"e75463","DOI":"10.1371\/journal.pone.0075463","article-title":"Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line","volume":"8","author":"Ueda","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cbi.2017.06.020_bib10","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2005.10.026","article-title":"Stem cells are units of natural selection in a colonial ascidian","volume":"123","author":"Laird","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cbi.2017.06.020_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488808786734006","article-title":"Aldehyde dehydrogenase as a marker for stem cells","volume":"3","author":"Moreb","year":"2008","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.cbi.2017.06.020_bib12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood-2008-05-156752","article-title":"Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems","volume":"113","author":"Levi","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cbi.2017.06.020_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.exphem.2011.12.006","article-title":"Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development","volume":"40","author":"Gasparetto","year":"2012","journal-title":"Exp. Hematol."},{"issue":"9","key":"10.1016\/j.cbi.2017.06.020_bib14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.freeradbiomed.2012.02.050","article-title":"Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal","volume":"52","author":"Black","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2017.06.020_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.23404","article-title":"Acute myeloid leukemia: 2013 update on risk-stratification and management","volume":"88","author":"Estey","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.cbi.2017.06.020_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0891-5849(03)00070-4","article-title":"Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage","volume":"34","author":"Pappa","year":"2003","journal-title":"Free Radic. Biol. Med."},{"issue":"35","key":"10.1016\/j.cbi.2017.06.020_bib17","doi-asserted-by":"crossref","first-page":"25668","DOI":"10.1074\/jbc.M702076200","article-title":"Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-\/-)\/Aldh1a1(-\/-) knock-out mice","volume":"282","author":"Lassen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2017.06.020_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2012.11.010","article-title":"Aldehyde dehydrogenases in cellular responses to oxidative\/electrophilic stress","volume":"56","author":"Singh","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.cbi.2017.06.020_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tcb.2012.09.007","article-title":"A\u00a0ROS rheostat for cell fate regulation","volume":"23","author":"Maryanovich","year":"2013","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.cbi.2017.06.020_bib20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/mt.2012.232","article-title":"Hematopoietic stem cell regeneration enhanced by ectopic expression of ROS-detoxifying enzymes in transplant mice","volume":"21","author":"Miao","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cbi.2017.06.020_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2012.10.532","article-title":"Redox regulation of stem\/progenitor cells and bone marrow niche","volume":"54","author":"Urao","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"7011","key":"10.1016\/j.cbi.2017.06.020_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature02989","article-title":"Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells","volume":"431","author":"Ito","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-011-0872-1","article-title":"Reactive oxygen species and hematopoietic stem cell senescence","volume":"94","author":"Shao","year":"2011","journal-title":"Int. J. Hematol."},{"issue":"11","key":"10.1016\/j.cbi.2017.06.020_bib24","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCRESAHA.109.209791","article-title":"Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaptation","volume":"105","author":"Hill","year":"2009","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.cbi.2017.06.020_bib25","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/cdd.2013.138","article-title":"Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance","volume":"20","author":"Dalleau","year":"2013","journal-title":"Cell Death Differ."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2017.06.020_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrfmmm.2011.03.006","article-title":"DNA damage induced by endogenous aldehydes: current state of knowledge","volume":"711","author":"Voulgaridou","year":"2011","journal-title":"Mutat. Res."},{"issue":"7","key":"10.1016\/j.cbi.2017.06.020_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/tx5001046","article-title":"Molecular mechanisms of aldehyde toxicity: a chemical perspective","volume":"27","author":"LoPachin","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2017.06.020_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2012.06.025","article-title":"An overview of the chemistry and biology of reactive aldehydes","volume":"59","author":"Fritz","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.cbi.2017.06.020_bib29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/tx300002q","article-title":"Protein carbonylation in a murine model for early alcoholic liver disease","volume":"25","author":"Galligan","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.cbi.2017.06.020_bib30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.exphem.2007.02.012","article-title":"Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions","volume":"35","author":"Ohta","year":"2007","journal-title":"Exp. Hematol."},{"issue":"5","key":"10.1016\/j.cbi.2017.06.020_bib31","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/MCB.24.5.1907-1917.2004","article-title":"Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1","volume":"24","author":"Pineault","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2017.06.020_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat. Res."},{"issue":"7354","key":"10.1016\/j.cbi.2017.06.020_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10192","article-title":"Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice","volume":"475","author":"Langevin","year":"2011","journal-title":"Nature"},{"issue":"7417","key":"10.1016\/j.cbi.2017.06.020_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nature11368","article-title":"Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function","volume":"489","author":"Garaycoechea","year":"2012","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2017.06.020_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2016.07.004","article-title":"Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells","volume":"119","author":"Van Wassenhove","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"18","key":"10.1016\/j.cbi.2017.06.020_bib36","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2013-06-507962","article-title":"Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients","volume":"122","author":"Hira","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2012.05.013","article-title":"Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53\/p21 DNA damage response that impairs hematopoietic stem and progenitor cells","volume":"11","author":"Ceccaldi","year":"2012","journal-title":"Cell Stem Cell."},{"issue":"10","key":"10.1016\/j.cbi.2017.06.020_bib38","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.18632\/oncotarget.6920","article-title":"Aldehyde dehydrogenase 1A1 in stem cells and cancer","volume":"7","author":"Tomita","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cbi.2017.06.020_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm00385a029","article-title":"The mechanism of activation of 4-hydroxycyclophosphamide","volume":"30","author":"Borch","year":"1987","journal-title":"J.\u00a0Med. Chem."},{"issue":"7","key":"10.1016\/j.cbi.2017.06.020_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2012.08.021","article-title":"ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors","volume":"328","author":"Huang","year":"2013","journal-title":"Cancer Lett."},{"issue":"22","key":"10.1016\/j.cbi.2017.06.020_bib42","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1182\/blood-2011-06-363960","article-title":"Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation","volume":"119","author":"Man","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2141.1982.tb03864.x","article-title":"4-hydroperoxycyclophosphamide: a model for eliminating residual human tumour cells and T-lymphocytes from the bone marrow graft","volume":"52","author":"Korbling","year":"1982","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.cbi.2017.06.020_bib44","first-page":"321","article-title":"Density-gradient separation of autologous bone marrow grafts before ex\u00a0vivo purging with 4-hydroperoxycyclophosphamide","volume":"6","author":"Rowley","year":"1990","journal-title":"Bone Marrow Transpl."},{"issue":"11","key":"10.1016\/j.cbi.2017.06.020_bib45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cbi.2017.06.020_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbmt.2010.07.007","article-title":"Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas","volume":"17","author":"Kasamon","year":"2011","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"8","key":"10.1016\/j.cbi.2017.06.020_bib47","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood.V83.8.2345.2345","article-title":"Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging","volume":"83","author":"Zhong","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cbi.2017.06.020_bib48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"28","key":"10.1016\/j.cbi.2017.06.020_bib49","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cbi.2017.06.020_bib50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3324\/haematol.2016.159053","article-title":"Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1","volume":"102","author":"Gasparetto","year":"2017","journal-title":"Haematologica"},{"issue":"6464","key":"10.1016\/j.cbi.2017.06.020_bib51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A\u00a0cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cbi.2017.06.020_bib52","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/bcj.2016.78","article-title":"Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors","volume":"6","author":"Venton","year":"2016","journal-title":"Blood Cancer J."},{"issue":"7","key":"10.1016\/j.cbi.2017.06.020_bib53","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2404721","article-title":"Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD\/SCID engrafting potential","volume":"21","author":"Cheung","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cbi.2017.06.020_bib54","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1634\/stemcells.2004-0292","article-title":"Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples","volume":"23","author":"Pearce","year":"2005","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.cbi.2017.06.020_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.29410","article-title":"The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients","volume":"137","author":"Hoang","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"15","key":"10.1016\/j.cbi.2017.06.020_bib56","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1182\/blood-2011-06-364182","article-title":"A\u00a0clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia","volume":"119","author":"Gerber","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cbi.2017.06.020_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3324\/haematol.2015.135194","article-title":"Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes","volume":"101","author":"Gerber","year":"2016","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.cbi.2017.06.020_bib58","doi-asserted-by":"crossref","first-page":"e78897","DOI":"10.1371\/journal.pone.0078897","article-title":"Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells","volume":"8","author":"Schuurhuis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2017.06.020_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2014.12.008","article-title":"N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes","volume":"234","author":"Morgan","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.cbi.2017.06.020_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/stem.563","article-title":"Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis","volume":"29","author":"Marcato","year":"2011","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.cbi.2017.06.020_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.exphem.2011.10.005","article-title":"Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance","volume":"40","author":"Ran","year":"2012","journal-title":"Exp. Hematol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927971730666X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927971730666X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:47:17Z","timestamp":1757857637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927971730666X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":61,"alternative-id":["S000927971730666X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.06.020","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}